Apple Inc. (NASDAQ: AAPL) director Arthur D. Levinson has sold 75,000 shares of the technology giant's common stock, a transaction valued at approximately $14.37 million.

Arthur D. Levinson, a director at Apple Inc. (NASDAQ: AAPL), has sold shares in the company according to a recent SEC filing. On February 3, Levinson sold 1,516 shares of Apple's common stock at an ...

Levinson is the chairman of Genentech, as well as being a co-lead director of Apple's board since 2005. He joined the company in 2000. He also served as a director of Google, Inc. from 2004 to 2009.

Calico Life Sciences LLC (Calico), a biotechnology organization focused on the biology of aging and age-related diseases, and founded by Alphabet and Arthur D. Levinson, Ph.D., today announced the ...

SAN FRANCISCO - Apple Inc. has named Arthur Levinson as its non-executive chairman, a move that rewards the longtime Apple board member who chose it over Google Inc. when the technology giants ...

Feb 1, 2022Purchase Arthur D. Levinson Director Derivative/Non-derivative$0.00 PER SHARE 1,986$0 Feb 2, 2021Sale Arthur D. Levinson Director Disposition$135.60 PER SHARE -3,416$-463,210 Feb 1 ...

Calico is the Google-backed life sciences company that is led by Arthur D. Levinson Ph.D. (former chairman and CEO of Genentech) and Hal V. Barron, M.D. (former Executive Vice President and Chief ...

Arthur D. Levinson, chief executive of Genentech, which announced positive trial results of a drug to control colon cancer, sending the company's stock up more than 50 percent.

Mr Levinson has been on the Apple board since 2000 The world's most valuable technology company, Apple, has named long-serving director Arthur Levinson as chairman of the board.

Apple Inc. (NASDAQ: AAPL) director Arthur D. Levinson has sold 75,000 shares of the technology giant's common stock, a transaction valued at approximately $14.37 million. According to the recent SEC ...